Header Logo

Connection

AJAY SHESHADRI to Humans

Back to Details
This is a "connection" page, showing publications AJAY SHESHADRI has written about Humans.
AJAY SHESHADRI
Connection Strength
0.682
Humans
  1. Coronavirus Disease-2019 in the Immunocompromised Host. Rheum Dis Clin North Am. 2025 Feb; 51(1):123-138.
    View in: PubMed
    Score: 0.019
  2. CT strain metrics allow for earlier diagnosis of bronchiolitis obliterans syndrome after hematopoietic cell transplant. Blood Adv. 2024 10 08; 8(19):5156-5165.
    View in: PubMed
    Score: 0.019
  3. Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis. Clin Lung Cancer. 2024 Nov; 25(7):624-633.e2.
    View in: PubMed
    Score: 0.019
  4. Respiratory Syncytial Virus Vaccination in the Adult Pulmonary Patient. Chest. 2024 Nov; 166(5):963-974.
    View in: PubMed
    Score: 0.018
  5. Coronavirus Disease-2019 in the Immunocompromised Host. Infect Dis Clin North Am. 2024 Mar; 38(1):213-228.
    View in: PubMed
    Score: 0.018
  6. Association of Preoperative Lung Function with Complications after Lobectomy Using Race-Neutral and Race-Specific Normative Equations. Ann Am Thorac Soc. 2024 Jan; 21(1):38-46.
    View in: PubMed
    Score: 0.018
  7. Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. Oncologist. 2023 Nov 02; 28(11):e1065-e1074.
    View in: PubMed
    Score: 0.018
  8. Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept. Front Immunol. 2023; 14:1249511.
    View in: PubMed
    Score: 0.018
  9. Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study. Cancer Med. 2023 09; 12(17):17753-17765.
    View in: PubMed
    Score: 0.017
  10. Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer. Clin Oncol (R Coll Radiol). 2023 10; 35(10):630-639.
    View in: PubMed
    Score: 0.017
  11. A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept. Immunohorizons. 2023 Jun 01; 7(6):421-430.
    View in: PubMed
    Score: 0.017
  12. Immunotherapy-related pneumonitis and the synergic impact of thoracic radiation and preexisting interstitial lung disease. Curr Opin Pulm Med. 2023 07 01; 29(4):248-255.
    View in: PubMed
    Score: 0.017
  13. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation. Transplant Cell Ther. 2023 03; 29(3):204.e1-204.e7.
    View in: PubMed
    Score: 0.017
  14. Coronavirus Disease-2019 in the Immunocompromised Host. Clin Chest Med. 2023 06; 44(2):395-406.
    View in: PubMed
    Score: 0.017
  15. Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease. Blood Adv. 2022 09 13; 6(17):4984-4986.
    View in: PubMed
    Score: 0.016
  16. Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation. Clin Ther. 2022 05; 44(5):755-765.e6.
    View in: PubMed
    Score: 0.016
  17. Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study. Cancer. 2022 07 15; 128(14):2736-2745.
    View in: PubMed
    Score: 0.016
  18. The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States. Blood Adv. 2022 03 08; 6(5):1566-1576.
    View in: PubMed
    Score: 0.016
  19. The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States. J Med Econ. 2022 Jan-Dec; 25(1):650-659.
    View in: PubMed
    Score: 0.016
  20. Pulmonary Function Testing in Patients with Tracheostomies: Feasibility and Technical Considerations. Lung. 2021 06; 199(3):307-310.
    View in: PubMed
    Score: 0.015
  21. Pulmonary Toxicities of Immunotherapy. Adv Exp Med Biol. 2021; 1342:357-375.
    View in: PubMed
    Score: 0.015
  22. Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients. Bone Marrow Transplant. 2021 03; 56(3):745-748.
    View in: PubMed
    Score: 0.014
  23. Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients. Ann Am Thorac Soc. 2020 10; 17(10):1329-1333.
    View in: PubMed
    Score: 0.014
  24. Quantitative Lung Imaging in Hematopoietic Cell Transplant Recipients: A Window Into the Physiology of Bronchiolitis Obliterans. Chest. 2020 09; 158(3):852-853.
    View in: PubMed
    Score: 0.014
  25. Immune-Related Adverse Events: Pneumonitis. Adv Exp Med Biol. 2020; 1244:255-269.
    View in: PubMed
    Score: 0.014
  26. Progression of the Radiologic Severity Index is associated with increased mortality and healthcare resource utilisation in acute leukaemia patients with pneumonia. BMJ Open Respir Res. 2019; 6(1):e000471.
    View in: PubMed
    Score: 0.014
  27. Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection. Transpl Infect Dis. 2019 Aug; 21(4):e13105.
    View in: PubMed
    Score: 0.013
  28. Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant. 2019 04; 25(4):800-809.
    View in: PubMed
    Score: 0.013
  29. Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections. PLoS One. 2018; 13(5):e0197418.
    View in: PubMed
    Score: 0.012
  30. Immune-Related Adverse Events: Pneumonitis. Adv Exp Med Biol. 2018; 995:131-149.
    View in: PubMed
    Score: 0.012
  31. Effect of Reducing Field of View on Multidetector Quantitative Computed Tomography Parameters of Airway Wall Thickness in Asthma. J Comput Assist Tomogr. 2015 Jul-Aug; 39(4):584-90.
    View in: PubMed
    Score: 0.010
  32. Critical review of bronchial thermoplasty: where should it fit into asthma therapy? Curr Allergy Asthma Rep. 2014 Nov; 14(11):470.
    View in: PubMed
    Score: 0.009
  33. Can computed tomography help us identify asthmatic phenotypes? J Allergy Clin Immunol. 2014 Mar; 133(3):739-40.
    View in: PubMed
    Score: 0.009
  34. Bronchial thermoplasty: a novel therapy for severe asthma. Clin Chest Med. 2013 Sep; 34(3):437-44.
    View in: PubMed
    Score: 0.009
  35. High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC. J Immunother Cancer. 2024 Dec 25; 12(12).
    View in: PubMed
    Score: 0.005
  36. Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2024 Sep; 21(9):1219-1237.
    View in: PubMed
    Score: 0.005
  37. Toxicity in the era of immune checkpoint inhibitor therapy. Front Immunol. 2024; 15:1447021.
    View in: PubMed
    Score: 0.005
  38. Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024 08 01; 210(3):262-280.
    View in: PubMed
    Score: 0.005
  39. Gravity- vs?Wall Suction-Driven Large-Volume Thoracentesis: A Randomized Controlled Study. Chest. 2024 Dec; 166(6):1573-1582.
    View in: PubMed
    Score: 0.005
  40. Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights. Nat Commun. 2024 Apr 11; 15(1):3152.
    View in: PubMed
    Score: 0.005
  41. Drug-induced Lung Disease in the Oncology Patient: From Cytotoxic Agents to Immunotherapy. Clin Chest Med. 2024 Jun; 45(2):325-337.
    View in: PubMed
    Score: 0.005
  42. Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept. Cell Rep Med. 2024 Mar 19; 5(3):101463.
    View in: PubMed
    Score: 0.005
  43. Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma. Radiother Oncol. 2024 04; 193:110121.
    View in: PubMed
    Score: 0.005
  44. Use of Quantitative CT Imaging to Identify Bronchial Thermoplasty Responders. Chest. 2024 Apr; 165(4):775-784.
    View in: PubMed
    Score: 0.004
  45. Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events. Front Immunol. 2023; 14:1322818.
    View in: PubMed
    Score: 0.004
  46. Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With Cancer. J Infect Dis. 2023 11 28; 228(11):1549-1558.
    View in: PubMed
    Score: 0.004
  47. Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators. Am J Respir Crit Care Med. 2023 11 01; 208(9):930-943.
    View in: PubMed
    Score: 0.004
  48. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A?GRADE assessment and international consensus approach. J Allergy Clin Immunol. 2023 08; 152(2):309-325.
    View in: PubMed
    Score: 0.004
  49. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID). J Patient Rep Outcomes. 2023 05 26; 7(1):48.
    View in: PubMed
    Score: 0.004
  50. Cloning a profibrotic stem cell variant in idiopathic pulmonary fibrosis. Sci Transl Med. 2023 04 26; 15(693):eabp9528.
    View in: PubMed
    Score: 0.004
  51. Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review. Int J Mol Sci. 2023 Apr 24; 24(9).
    View in: PubMed
    Score: 0.004
  52. Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2023 03; 20(3):341-353.
    View in: PubMed
    Score: 0.004
  53. Imaging of Immune Checkpoint Inhibitor Immunotherapy for Non-Small Cell Lung Cancer. Radiographics. 2022 Nov-Dec; 42(7):1956-1974.
    View in: PubMed
    Score: 0.004
  54. Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer. Radiother Oncol. 2022 11; 176:149-156.
    View in: PubMed
    Score: 0.004
  55. Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial. Sci Rep. 2022 08 23; 12(1):14367.
    View in: PubMed
    Score: 0.004
  56. Quantitative CT Characteristics of Cluster Phenotypes in the Severe Asthma Research Program Cohorts. Radiology. 2022 08; 304(2):450-459.
    View in: PubMed
    Score: 0.004
  57. Airway disease in hematologic malignancies. Expert Rev Respir Med. 2022 03; 16(3):303-313.
    View in: PubMed
    Score: 0.004
  58. Cavitary Lesions in a Hematopoietic Stem Cell Transplant Patient. Arch Bronconeumol. 2021 12; 57(12):768.
    View in: PubMed
    Score: 0.004
  59. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Transplant Cell Ther. 2021 10; 27(10):817-835.
    View in: PubMed
    Score: 0.004
  60. Nucleic Acid-based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2021 05 01; 203(9):1070-1087.
    View in: PubMed
    Score: 0.004
  61. Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease. Transplant Cell Ther. 2021 07; 27(7):616.e1-616.e6.
    View in: PubMed
    Score: 0.004
  62. Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: Results from SARP-3. J Allergy Clin Immunol. 2021 09; 148(3):752-762.
    View in: PubMed
    Score: 0.004
  63. Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications. Front Immunol. 2020; 11:590494.
    View in: PubMed
    Score: 0.004
  64. Complications following symptom-limited thoracentesis using suction. Eur Respir J. 2020 11; 56(5).
    View in: PubMed
    Score: 0.004
  65. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. J Immunother Cancer. 2020 10; 8(2).
    View in: PubMed
    Score: 0.004
  66. Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal: An Exploratory Study. J Bronchology Interv Pulmonol. 2020 Jan; 27(1):4-13.
    View in: PubMed
    Score: 0.003
  67. Routine Microbiologic Studies of Pleural Fluid Specimens in Cancer Patients. Am J Med. 2020 02; 133(2):240-244.
    View in: PubMed
    Score: 0.003
  68. A Design-Based Stereologic Method to Quantify the Tissue Changes Associated with a Novel Drug-Eluting Tracheobronchial Stent. Respiration. 2019; 98(1):60-69.
    View in: PubMed
    Score: 0.003
  69. Predicting Lung Function Following Lobectomy: A New Method to Adjust for Inherent Selection Bias. Respiration. 2018; 96(5):434-445.
    View in: PubMed
    Score: 0.003
  70. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis. 2018 Dec; 20(6):e12994.
    View in: PubMed
    Score: 0.003
  71. Associations between household air pollution and reduced lung function in women and children in rural southern India. J Appl Toxicol. 2018 11; 38(11):1405-1415.
    View in: PubMed
    Score: 0.003
  72. Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
    View in: PubMed
    Score: 0.003
  73. Radiomics to predict immunotherapy-induced pneumonitis: proof of concept. Invest New Drugs. 2018 08; 36(4):601-607.
    View in: PubMed
    Score: 0.003
  74. Associations in asthma between quantitative computed tomography and?bronchial biopsy-derived airway remodelling. Eur Respir J. 2017 05; 49(5).
    View in: PubMed
    Score: 0.003
  75. Calcium channel blocker reduces airway remodeling-or does it? Am J Respir Crit Care Med. 2015 Apr 15; 191(8):863-4.
    View in: PubMed
    Score: 0.002
  76. Regional ventilation changes in severe asthma after bronchial thermoplasty with (3)He MR imaging and CT. Radiology. 2015 Jan; 274(1):250-9.
    View in: PubMed
    Score: 0.002
  77. Longitudinal changes in airway remodeling and air trapping in severe asthma. Acad Radiol. 2014 Aug; 21(8):986-93.
    View in: PubMed
    Score: 0.002
  78. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA. 2014 May; 311(20):2083-91.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.